Australia markets close in 6 hours 9 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
494.64+13.48 (+2.80%)
At close: 4:00PM EDT

494.30 -0.34 (-0.07%)
After hours: 7:45PM EDT

Currency in USD
Earnings estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts17172222
Avg. Estimate10.214.1345.2240.32
Low estimate7.117.4233.633.22
High estimate20.1222.3857.8154.44
Year ago EPS6.67.1631.4745.22
Revenue estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts16162020
Avg. Estimate2.64B3.83B12.06B11.37B
Low estimate2.04B2.53B9.87B10.09B
High estimate3.58B5.63B15.89B14.18B
Year ago sales1.83BN/A8.5B12.06B
Sales growth (year/est)44.60%N/A42.00%-5.70%
Earnings history30/03/202029/06/202029/09/202030/12/2020
Est. EPS6.135.987.138.39
Actual EPS6.67.168.369.53
Difference0.471.181.231.14
Surprise %7.70%19.70%17.30%13.60%
EPS trendCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Current estimate10.214.1345.2240.32
7 days ago10.2114.3545.2839.72
30 days ago10.0713.6444.7739.73
60 days ago9.5512.7943.6439.66
90 days ago8.218.6337.2639.82
EPS revisionsCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/A1
Up last 30 days1422
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.54.50%N/AN/AN/A
Next qtr.97.30%N/AN/AN/A
Current year43.70%N/AN/AN/A
Next year-10.80%N/AN/AN/A
Next 5 years (per annum)11.11%N/AN/AN/A
Past 5 years (per annum)21.60%N/AN/AN/A